Search clinical trials for: Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel

Total 144 results

Zydus Lifesciences Limited

Completed

To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel

Acne Vulgaris

United States, India
Watson Laboratories, Inc.

Completed

Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne Vulgaris

Acne Vulgaris
Padagis LLC

Completed

A Study to Compare Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% to Acanya® Topical Gel in the Treatment of Acne Vulgaris

Acne
Padagis LLC

Completed

Clinical Study Between Two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel Formulations

Acne Vulgaris
Glenmark Pharmaceuticals Ltd. India

Completed

To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris.

Acne Vulgaris

United States, Belize
Actavis Inc.

Completed

Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications

Acne Vulgaris

United States
Sanofi

Completed

A Pilot, Multi-Center, Patient Preference Study Comparing Two Clindamycin/Benzoyl Peroxide Gels.

Acne Vulgaris
University of Southern California

Completed

Topical Treatment and Prevalence of P. Acnes

Surgical Site Infection

United States
Taro Pharmaceuticals USA

Completed

Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel to Acanya® Gel and Both to a Vehicle Control in the Treatment of Acne Vulgaris

Acne Vulgaris
Taro Pharmaceuticals USA

Completed

A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onexton™ Gel in the Treatment of Acne Vulgaris

Acne Vulgaris
Padagis LLC

Completed

Comparative Safety and Efficacy of Two Treatments in the Treatment of Acne Vulgaris

Acne

United States
Zeichner, Joshua, M.D.

Unknown

A Study Comparing Combination Clindamycin Phosphate/Tretinoin Gel Alone Versus With Benzoyl Peroxide Foaming Cloths for Facial Acne

Acne Vulgaris

United States
Taro Pharmaceuticals USA

Completed

A Study Comparing Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to Duac® Topical Gel in the Treatment of Acne Vulgaris

Acne Vulgaris
Stiefel, a GSK Company
GlaxoSmithKline; Quintiles, Inc.; Rho, Inc.

Completed

Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne

Acne Vulgaris

United States, Canada, Belize
Padagis LLC

Completed

Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical Gels

Acne Vulgaris
Taro Pharmaceuticals USA

Completed

A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne Vulgaris

Acne Vulgaris
Zeichner, Joshua, M.D.

Unknown

Safety and Tolerability of Acanya Gel in Combination With Atralin Gel for Acne Vulgaris

Acne Vulgaris

United States
Mahidol University

Withdrawn

A Study of Efficacy of Benzoyl Peroxide Regimens in Treatment of Unpleasant Foot Odor

Foot Dermatoses | Benzoyl Peroxide

Thailand
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of 0.1% Tazorac Cream When Used in Combination With Either Duac Gel or Acanya Gel for the Treatment of Facial Acne Vulgaris (C0000-411)

Acne Vulgaris
Stiefel, a GSK Company
GlaxoSmithKline

Completed

W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With Acne

Acne Vulgaris
Wake Forest University Health Sciences
Bausch Health Americas, Inc.

Not yet recruiting

Experience With Topical Acne Treatment

Acne

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With Acne

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne

Acne Vulgaris

United States
Cosmetique Active International

Completed

Efficacy and Tolerance of Formula 609613 37 in Acneic Patients

Acne
Icahn School of Medicine at Mount Sinai
Bausch Health Americas, Inc.

Completed

Perimenstrual Acne With Clindamycin Phosphate and Benzoyl Peroxide

Actinic Keratosis

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications

Acne Vulgaris

United States
Wake Forest University

Completed

A Novel Method to Improve Acne Outcomes

Acne Vulgaris

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

Comparative Efficacy and Safety of Benzoyl Peroxide Used in Combination With Clindamycin vs. Benzoyl Peroxide Used in Combination With Clindamycin and Doxycycline in the Treatment of Moderate Acne

Acne

United States
Laserklinik Karlsruhe

Completed

Pulsed Dye Laser Treatment of Acne Vulgaris

Acne Vulgaris

Germany
Dow Pharmaceutical Sciences

Completed

A Clinical Study Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris

Acne Vulgaris

United States, Belize, Canada
Dow Pharmaceutical Sciences

Completed

A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris

Acne Vulgaris

United States
Medicis Global Service Corporation

Completed

Combination Treatment for Moderate to Severe Acne

Acne

United States
Galderma R&D

Completed

Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris

Acne Vulgaris

United States
Galderma R&D

Completed

Efficacy and Safety Study of 2 Different Concentrations of CD1579 Gels Versus Vehicle in the Treatment of Acne Vulgaris.

Acne Vulgaris

Japan
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Comparative Study of the Tolerability of Two Combination Therapies for the Treatment of Acne

Acne Vulgaris

Argentina
GlaxoSmithKline

Completed

Study STF115288, a Clinical Confirmation Study of GI148512 in the Treatment of Acne Vulgaris in Japanese Subjects

Acne Vulgaris

Japan
Nantes University Hospital

Recruiting

Optimization of Skin Preparation to Reduce Cutibacterium Acnes Colonization in Superficial and Deep Samples During Prosthetic Shoulder Surgery in Male Patients (OPRICA)

Cutibacterium Acnes Infection

France
Allergan

Completed

A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne

Acne Vulgaris

United States
University of Wisconsin, Madison

Completed

Blue Light Therapy of C. Acnes

Acne

United States
GlaxoSmithKline

Completed

Japanese Phase 1 Study of GSK2585823 (JPN P1)

Acne Vulgaris

Japan
Colorado Joint Replacement

Recruiting

Cutibacterium Dermal Colonization: Implications for Total Hip Arthroplasty

Degenerative Osteoarthritis

United States
Galderma R&D

Completed

Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris

Acne Vulgaris

United States
Chulalongkorn University

Completed

2940nm Er:YAG Laser Versus Benzoyl Peroxide Gel for the Treatment of Inflammatory Acne

Acne Vulgaris

Thailand
Massachusetts General Hospital
Medicis Pharmaceutical Corporation

Completed

Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea

Rosacea

United States
Callender Center for Clinical Research
Society Hill Dermatology

Unknown

Efficacy & Safety of Clindamycin and Tretinoin in Acne

Acne

United States
Galderma R&D

Completed

Epiduo Pediatric Acne Study

Acne

United States, Canada
Padagis LLC

Completed

Comparative Safety and Bioequivalence of Two Treatments in the Treatment of Acne Vulgaris

Acne
Actavis Inc.

Completed

Clinical End Point Study of Generic Adapalene and Benzoyl Peroxide Gel Versus Epiduo® Forte Gel in Treatment of Acne Vulgaris

Acne

United States, Belize

3

Subscribe